by Heather Dillaway | Oct 21, 2010 | Menopause, New Research, Newspapers, Pharmaceutical
Yes, the hormone therapies prescribed for women in perimenopause and beyond have already been suspect. Especially after the initial Women’s Health Initiative (WHI) trial results in 2002 (but even before that), researchers documented the health risks associated with...
by Elizabeth Kissling | Apr 18, 2010 | Menopause, New Research, Newspapers, Pharmaceutical
Guest Post by Paula S. Derry, Ph.D. Déjà vu An article in today’s New York Times Magazine recounts the author’s experience with a debilitating depression that began during her perimenopause, the transitional time leading up to menopause. For her, prescription...
by Elizabeth Kissling | Jan 5, 2010 | Menopause, New Research, Pharmaceutical
As we have often noted here, one of the key reasons the marketing of hormone therapy for menopausal women has been so successful is the misguided belief that menopause is an estrogen-deficiency disease. Among other purported disadvantages of the decline in estrogen...